Can You Sue for Vaccine Injury? Understanding Vaccine Court and the Vaccine Injury Compensation Program
Can you sue for vaccine injury? Learn how vaccine court works, what the Vaccine Injury Compensation Program is, and why most vaccine injury claims proceed through the VICP instead of civil lawsuits.
Short Answer
Yes—but vaccine injury claims must first be filed through the Vaccine Injury Compensation Program (VICP) rather than through traditional civil lawsuits against pharmaceutical companies. The VICP, often referred to as “vaccine court,” allows individuals to seek compensation if they can demonstrate that a vaccine more likely than not caused their injury. Individuals can reject the vaccine court decision and sue the vaccine manufacturer directly for a manufacturing defect or failure to warn defect.
Introduction
If someone believes they were injured by a vaccine, the first question they often ask is simple: can you sue for vaccine injury?
At first glance, suing a pharmaceutical company may seem like the most logical path. In most product liability cases, injured individuals pursue compensation directly from manufacturers in civil court.
But vaccine injury cases are different. In practice, traditional lawsuits against vaccine manufacturers are rarely the most effective way to obtain compensation. The legal framework governing vaccines was specifically designed to address the unique scientific and evidentiary challenges involved in proving vaccine injury claims.
Lawyers representing injured individuals routinely evaluate where a case has the best chance of success. In the vaccine context, decades of legal experience have shown that the most realistic path to justice and compensation is not traditional product liability litigation—it is the Vaccine Injury Compensation Program (VICP).
Rather than filing lawsuits in state or federal courts, most vaccine injury claims proceed through this specialized federal system, often referred to as “vaccine court.” Created by Congress in 1986, the VICP was designed to resolve vaccine injury claims under a more flexible evidentiary standard while maintaining a stable national vaccine supply.
Understanding how this system works—and why it often provides a more practical path to compensation than traditional lawsuits—is essential for anyone navigating vaccine injury claims in the United States.
Why Vaccine Lawsuits Work Differently
Vaccines occupy a unique place in American law and public health policy.
Unlike most pharmaceutical products, vaccines are administered to millions of healthy individuals, including infants and children, to prevent infectious diseases. Because vaccines are recommended as part of national immunization programs, Congress concluded that traditional product liability litigation was not the most efficient system for resolving vaccine injury claims.
During the early 1980s, vaccine manufacturers faced increasing litigation related to vaccines—particularly the DTP vaccine. As lawsuits increased, the number of companies producing vaccines declined dramatically.
By the mid-1980s, the number of vaccine manufacturers in the United States had fallen from 18 companies to just four. Policymakers became concerned that continued litigation could destabilize the vaccine market and threaten the nation’s ability to produce essential vaccines.
Congress responded by creating a new legal framework designed to accomplish two goals:
Maintain a stable vaccine supply.
Ensure that individuals who experience rare vaccine injuries can receive compensation.
The result was the National Childhood Vaccine Injury Act of 1986.
The National Childhood Vaccine Injury Act
The National Childhood Vaccine Injury Act established the Vaccine Injury Compensation Program (VICP).
Under this law, individuals who believe they were injured by certain vaccines may file claims in the U.S. Court of Federal Claims, where cases are decided by judicial officers known as Special Masters.
The program operates as a no-fault compensation system, meaning petitioners do not need to prove negligence, defective design, or wrongdoing by vaccine manufacturers.
Instead, the central legal question is:
Did the vaccine more likely than not cause the injury?
This lower evidentiary standard reflects Congress’s recognition that traditional tort litigation would make compensation extremely difficult in many vaccine injury cases. Vaccines work by stimulating the immune system, and in rare cases that immune response may become abnormal in certain individuals. Proving product defect in such circumstances would often be extraordinarily difficult.
The VICP was therefore designed to focus on causation rather than fault.
The Vaccine Injury Compensation Program
The Vaccine Injury Compensation Program functions as a specialized legal system dedicated to resolving vaccine injury claims.
When a claim is filed, the Department of Health and Human Services reviews the medical evidence to determine whether the government will concede causation or contest the claim.
If a petitioner successfully proves that a vaccine caused their injury, compensation may include:
reimbursement for past and future medical expenses
compensation for lost wages or reduced earning capacity
pain and suffering damages
compensation for future care needs
attorney’s fees and litigation costs
Compensation is paid from the Vaccine Injury Compensation Trust Fund, which is funded through an excise tax on each covered vaccine dose.
Since its creation, the program has awarded billions of dollars in compensation to individuals and families who proved vaccine injuries. See here for how the Vaccine Injury Program works.
What the Supreme Court Said in Bruesewitz v. Wyeth
In 2011, the U.S. Supreme Court addressed vaccine liability in the case Bruesewitz v. Wyeth.
The Court held that the Vaccine Act largely preempts design defect lawsuits against vaccine manufacturers for vaccines covered under the VICP. In practical terms, individuals generally cannot sue vaccine manufacturers claiming that a vaccine should have been designed differently.
However, the Court did not eliminate all potential lawsuits.
Claims involving manufacturing defects or failure to warn may still be pursued under certain circumstances. Even in those cases, the claimant must first file a petition in the Vaccine Injury Compensation Program before pursuing civil litigation.
The decision reinforced Congress’s intent that vaccine injury claims should primarily be resolved through the specialized compensation system created by the Vaccine Act.
When Lawsuits Are Still Possible
Although the Vaccine Injury Compensation Program handles most vaccine injury claims, civil litigation can still occur in certain circumstances.
After filing a petition in vaccine court, petitioners may choose to opt out after 240 days and pursue some claims in civil court.
Civil lawsuits may also arise in cases involving:
manufacturing defects
failure to warn claims
vaccines not covered under the Vaccine Injury Compensation Program
One notable example involves COVID-19 vaccines, which currently fall under a different federal compensation program.
Why Vaccine Court Exists
The Vaccine Injury Compensation Program reflects an important public policy principle.
Vaccines are one of the most effective tools for preventing infectious diseases, but no medical intervention is completely risk-free. Congress recognized that if society encourages widespread vaccination for the public good, individuals who experience rare vaccine injuries should not bear the consequences alone.
The VICP was created to provide a fair compensation system while protecting the stability of the national vaccine supply.
In many cases, this framework actually makes compensation more accessible than traditional pharmaceutical litigation. Petitioners do not need to prove negligence or defective design—they only need to demonstrate that the vaccine more likely than not caused the injury.
For many injured individuals, that legal structure offers a far more practical path to compensation than attempting to sue pharmaceutical companies directly.
Frequently Asked Questions
Can you sue Pfizer for vaccine injury?
Most vaccine injury claims (except Covid-19 vaccine) must first be filed through the Vaccine Injury Compensation Program (VICP) rather than through traditional lawsuits against pharmaceutical companies. Pfizer Covid-19 vaccine injury claims can only be filed in the CICP, not the VICP
Can you sue for COVID vaccine injury?
COVID-19 vaccine injury claims currently fall under the Countermeasures Injury Compensation Program (CICP) created under the PREP Act, which operates differently from the VICP.
What is vaccine court?
“Vaccine court” is the informal name used to describe the Vaccine Injury Compensation Program, which operates within the U.S. Court of Federal Claims and is presided over by Special Masters.
How do vaccine injury claims work?
A vaccine injury claim begins when a petitioner files a petition in the U.S. Court of Federal Claims. The Department of Health and Human Services evaluates the medical evidence and determines whether compensation should be awarded. The burden of proof is lower than in civil court and the directive of the Vaccine Act is to compensate the vaccine injured.